Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Abortion, Induced | 8 | 2024 | 135 | 4.620 |
Why?
|
| Pregnancy | 47 | 2024 | 3018 | 4.350 |
Why?
|
| Opioid-Related Disorders | 7 | 2023 | 189 | 3.720 |
Why?
|
| Hypertension, Pregnancy-Induced | 5 | 2023 | 75 | 2.810 |
Why?
|
| Labor, Induced | 5 | 2024 | 30 | 2.750 |
Why?
|
| Pregnancy Complications, Infectious | 5 | 2024 | 117 | 2.470 |
Why?
|
| Premature Birth | 4 | 2023 | 117 | 2.420 |
Why?
|
| Pre-Eclampsia | 6 | 2023 | 254 | 2.370 |
Why?
|
| HIV Infections | 7 | 2024 | 840 | 2.230 |
Why?
|
| Buprenorphine | 3 | 2022 | 41 | 2.140 |
Why?
|
| Pregnancy Complications | 7 | 2024 | 345 | 2.040 |
Why?
|
| Meningomyelocele | 3 | 2024 | 24 | 2.030 |
Why?
|
| Methadone | 4 | 2022 | 46 | 1.830 |
Why?
|
| Obstetrics | 3 | 2024 | 123 | 1.660 |
Why?
|
| Opiate Substitution Treatment | 4 | 2022 | 40 | 1.570 |
Why?
|
| Reproductive Health | 3 | 2017 | 34 | 1.480 |
Why?
|
| Postpartum Period | 5 | 2024 | 144 | 1.480 |
Why?
|
| Pregnancy Outcome | 4 | 2022 | 254 | 1.460 |
Why?
|
| Gestational Age | 6 | 2024 | 329 | 1.440 |
Why?
|
| Female | 49 | 2024 | 46202 | 1.420 |
Why?
|
| Prenatal Care | 5 | 2024 | 77 | 1.420 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2023 | 242 | 1.410 |
Why?
|
| Hypertension | 4 | 2024 | 745 | 1.280 |
Why?
|
| Humans | 58 | 2024 | 89357 | 1.090 |
Why?
|
| Gynecology | 3 | 2024 | 129 | 1.060 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 319 | 1.000 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 304 | 1.000 |
Why?
|
| Delivery, Obstetric | 4 | 2024 | 118 | 0.980 |
Why?
|
| Cesarean Section | 2 | 2024 | 142 | 0.970 |
Why?
|
| Misoprostol | 1 | 2024 | 15 | 0.940 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2024 | 69 | 0.940 |
Why?
|
| Pandemics | 2 | 2020 | 773 | 0.930 |
Why?
|
| Long-Acting Reversible Contraception | 1 | 2024 | 12 | 0.920 |
Why?
|
| Intimate Partner Violence | 1 | 2024 | 28 | 0.900 |
Why?
|
| Contraception Behavior | 1 | 2024 | 28 | 0.900 |
Why?
|
| Tertiary Care Centers | 1 | 2024 | 106 | 0.880 |
Why?
|
| Fetofetal Transfusion | 1 | 2022 | 8 | 0.860 |
Why?
|
| Labor Pain | 1 | 2022 | 6 | 0.850 |
Why?
|
| Fellowships and Scholarships | 1 | 2024 | 122 | 0.830 |
Why?
|
| Residence Characteristics | 1 | 2024 | 202 | 0.830 |
Why?
|
| Racism | 3 | 2019 | 89 | 0.820 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2024 | 260 | 0.820 |
Why?
|
| Adult | 22 | 2024 | 26607 | 0.790 |
Why?
|
| Cytomegalovirus Infections | 1 | 2022 | 148 | 0.760 |
Why?
|
| Substance-Related Disorders | 4 | 2020 | 415 | 0.760 |
Why?
|
| Young Adult | 11 | 2024 | 6312 | 0.760 |
Why?
|
| Refugees | 2 | 2022 | 6 | 0.750 |
Why?
|
| Patient Rights | 1 | 2020 | 16 | 0.740 |
Why?
|
| Viremia | 1 | 2020 | 49 | 0.740 |
Why?
|
| Retrospective Studies | 11 | 2024 | 9057 | 0.730 |
Why?
|
| Perinatal Care | 1 | 2020 | 19 | 0.730 |
Why?
|
| Contraindications, Drug | 1 | 2020 | 4 | 0.730 |
Why?
|
| Pre-Exposure Prophylaxis | 1 | 2023 | 147 | 0.730 |
Why?
|
| Cefazolin | 1 | 2020 | 7 | 0.730 |
Why?
|
| Home Childbirth | 1 | 2020 | 2 | 0.730 |
Why?
|
| Pregnancy, High-Risk | 1 | 2020 | 16 | 0.720 |
Why?
|
| Cerclage, Cervical | 1 | 2020 | 5 | 0.720 |
Why?
|
| Indomethacin | 1 | 2020 | 59 | 0.720 |
Why?
|
| Labor, Obstetric | 1 | 2020 | 46 | 0.720 |
Why?
|
| Coronavirus | 1 | 2020 | 18 | 0.710 |
Why?
|
| Mothers | 1 | 2021 | 142 | 0.710 |
Why?
|
| Emigrants and Immigrants | 1 | 2020 | 43 | 0.710 |
Why?
|
| Prisoners | 1 | 2020 | 45 | 0.700 |
Why?
|
| Acculturation | 1 | 2020 | 15 | 0.700 |
Why?
|
| Fetus | 2 | 2023 | 232 | 0.700 |
Why?
|
| Poverty | 1 | 2021 | 180 | 0.690 |
Why?
|
| Obstetric Labor, Premature | 1 | 2020 | 58 | 0.690 |
Why?
|
| Child Development | 1 | 2021 | 167 | 0.680 |
Why?
|
| Mass Screening | 1 | 2024 | 636 | 0.660 |
Why?
|
| Infant, Newborn | 7 | 2022 | 2486 | 0.640 |
Why?
|
| Attitude of Health Personnel | 1 | 2024 | 645 | 0.640 |
Why?
|
| Cost-Benefit Analysis | 4 | 2022 | 461 | 0.600 |
Why?
|
| Siblings | 1 | 2017 | 111 | 0.580 |
Why?
|
| Violence | 2 | 2017 | 153 | 0.570 |
Why?
|
| Music | 1 | 2017 | 31 | 0.560 |
Why?
|
| Anti-HIV Agents | 1 | 2019 | 159 | 0.560 |
Why?
|
| Police | 1 | 2017 | 24 | 0.550 |
Why?
|
| Internship and Residency | 2 | 2024 | 1045 | 0.550 |
Why?
|
| Bioethical Issues | 1 | 2016 | 38 | 0.540 |
Why?
|
| Blood Pressure | 1 | 2020 | 900 | 0.540 |
Why?
|
| Altruism | 1 | 2016 | 34 | 0.520 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2016 | 109 | 0.520 |
Why?
|
| Personal Autonomy | 1 | 2016 | 116 | 0.510 |
Why?
|
| Minority Groups | 1 | 2017 | 146 | 0.510 |
Why?
|
| Cohort Studies | 4 | 2024 | 2872 | 0.510 |
Why?
|
| United States | 8 | 2024 | 6989 | 0.510 |
Why?
|
| Physicians | 1 | 2022 | 690 | 0.490 |
Why?
|
| Peripartum Period | 3 | 2024 | 30 | 0.490 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 788 | 0.480 |
Why?
|
| Global Health | 1 | 2016 | 187 | 0.470 |
Why?
|
| Chorioamnionitis | 2 | 2024 | 21 | 0.470 |
Why?
|
| Watchful Waiting | 3 | 2022 | 63 | 0.450 |
Why?
|
| Consumer Advocacy | 1 | 2013 | 10 | 0.450 |
Why?
|
| Healthcare Disparities | 4 | 2024 | 420 | 0.430 |
Why?
|
| Antibiotic Prophylaxis | 3 | 2024 | 77 | 0.420 |
Why?
|
| Poverty Areas | 1 | 2012 | 37 | 0.410 |
Why?
|
| Analgesics, Opioid | 3 | 2022 | 444 | 0.410 |
Why?
|
| Population Density | 1 | 2012 | 61 | 0.410 |
Why?
|
| Politics | 1 | 2012 | 52 | 0.410 |
Why?
|
| Reproductive Rights | 2 | 2024 | 2 | 0.410 |
Why?
|
| Physician's Role | 1 | 2013 | 177 | 0.390 |
Why?
|
| Illinois | 2 | 2024 | 480 | 0.380 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2013 | 179 | 0.360 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2024 | 838 | 0.360 |
Why?
|
| Logistic Models | 3 | 2020 | 1213 | 0.360 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2020 | 46 | 0.350 |
Why?
|
| Anthropology, Medical | 2 | 2022 | 2 | 0.350 |
Why?
|
| Qualitative Research | 4 | 2024 | 296 | 0.350 |
Why?
|
| Narcotic Antagonists | 2 | 2022 | 160 | 0.340 |
Why?
|
| Education, Medical, Graduate | 1 | 2013 | 393 | 0.330 |
Why?
|
| San Francisco | 2 | 2020 | 24 | 0.320 |
Why?
|
| Social Justice | 2 | 2019 | 54 | 0.290 |
Why?
|
| Linear Models | 2 | 2020 | 421 | 0.290 |
Why?
|
| California | 2 | 2018 | 144 | 0.290 |
Why?
|
| Parity | 2 | 2024 | 96 | 0.270 |
Why?
|
| Child | 3 | 2023 | 7174 | 0.270 |
Why?
|
| Multivariate Analysis | 2 | 2020 | 988 | 0.260 |
Why?
|
| Time Factors | 2 | 2024 | 5338 | 0.250 |
Why?
|
| Prospective Studies | 3 | 2023 | 4289 | 0.240 |
Why?
|
| Uterine Rupture | 1 | 2024 | 7 | 0.240 |
Why?
|
| Lebanon | 2 | 2016 | 3 | 0.240 |
Why?
|
| Health Policy | 2 | 2016 | 185 | 0.240 |
Why?
|
| Abortifacient Agents, Nonsteroidal | 1 | 2024 | 11 | 0.240 |
Why?
|
| Laminaria | 1 | 2023 | 4 | 0.230 |
Why?
|
| Dilatation | 1 | 2023 | 48 | 0.230 |
Why?
|
| Patient Discharge | 2 | 2024 | 320 | 0.230 |
Why?
|
| Eligibility Determination | 1 | 2023 | 36 | 0.220 |
Why?
|
| Hysterectomy | 1 | 2024 | 151 | 0.220 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2023 | 59 | 0.220 |
Why?
|
| Oxytocin | 1 | 2023 | 73 | 0.220 |
Why?
|
| Pregnancy, Twin | 1 | 2022 | 7 | 0.220 |
Why?
|
| Fetoscopy | 1 | 2022 | 8 | 0.220 |
Why?
|
| Infant | 2 | 2021 | 3160 | 0.210 |
Why?
|
| Insurance Coverage | 1 | 2024 | 120 | 0.210 |
Why?
|
| Contraception | 1 | 2024 | 93 | 0.210 |
Why?
|
| Lasers | 1 | 2022 | 107 | 0.210 |
Why?
|
| Naloxone | 1 | 2022 | 67 | 0.210 |
Why?
|
| Abortion, Legal | 1 | 2022 | 26 | 0.210 |
Why?
|
| Laser Coagulation | 1 | 2022 | 56 | 0.210 |
Why?
|
| Adolescent | 3 | 2020 | 9263 | 0.210 |
Why?
|
| Conscience | 1 | 2022 | 20 | 0.210 |
Why?
|
| Aftercare | 1 | 2023 | 87 | 0.200 |
Why?
|
| Pregnancy Trimester, First | 1 | 2022 | 63 | 0.200 |
Why?
|
| Cytomegalovirus | 1 | 2022 | 78 | 0.200 |
Why?
|
| Heroin | 1 | 2022 | 11 | 0.200 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2023 | 97 | 0.200 |
Why?
|
| Wechsler Scales | 1 | 2021 | 21 | 0.200 |
Why?
|
| Risk | 2 | 2022 | 657 | 0.190 |
Why?
|
| Wireless Technology | 1 | 2021 | 21 | 0.190 |
Why?
|
| Risk Factors | 2 | 2023 | 5499 | 0.190 |
Why?
|
| Gender Dysphoria | 1 | 2021 | 9 | 0.190 |
Why?
|
| Family | 1 | 2023 | 325 | 0.190 |
Why?
|
| Wearable Electronic Devices | 1 | 2021 | 26 | 0.190 |
Why?
|
| Informed Consent | 2 | 2023 | 275 | 0.180 |
Why?
|
| Pregnant Women | 1 | 2020 | 41 | 0.180 |
Why?
|
| Hospitals | 1 | 2023 | 299 | 0.180 |
Why?
|
| Uterine Cervical Incompetence | 1 | 2020 | 4 | 0.180 |
Why?
|
| Dilatation, Pathologic | 1 | 2020 | 55 | 0.180 |
Why?
|
| Self Report | 1 | 2022 | 297 | 0.180 |
Why?
|
| Cervix Uteri | 1 | 2020 | 70 | 0.180 |
Why?
|
| Sterilization, Involuntary | 1 | 2019 | 1 | 0.170 |
Why?
|
| Monitoring, Physiologic | 1 | 2021 | 266 | 0.170 |
Why?
|
| Viral Load | 1 | 2020 | 145 | 0.170 |
Why?
|
| Physical Examination | 1 | 2020 | 148 | 0.170 |
Why?
|
| Chicago | 1 | 2024 | 1427 | 0.160 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 148 | 0.160 |
Why?
|
| Transgender Persons | 1 | 2021 | 107 | 0.160 |
Why?
|
| Surveys and Questionnaires | 2 | 2024 | 2624 | 0.160 |
Why?
|
| Birth Rate | 1 | 2018 | 12 | 0.160 |
Why?
|
| Counseling | 1 | 2020 | 164 | 0.160 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 860 | 0.160 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 167 | 0.150 |
Why?
|
| Body Mass Index | 2 | 2024 | 773 | 0.150 |
Why?
|
| Patient Safety | 1 | 2020 | 218 | 0.150 |
Why?
|
| Decision Making | 1 | 2023 | 667 | 0.150 |
Why?
|
| Betacoronavirus | 1 | 2020 | 261 | 0.140 |
Why?
|
| Social Marginalization | 1 | 2017 | 2 | 0.140 |
Why?
|
| Semantics | 1 | 2017 | 48 | 0.140 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 784 | 0.140 |
Why?
|
| Law Enforcement | 1 | 2017 | 10 | 0.140 |
Why?
|
| Physician-Patient Relations | 1 | 2022 | 625 | 0.140 |
Why?
|
| Homicide | 1 | 2017 | 46 | 0.140 |
Why?
|
| Family Planning Services | 1 | 2017 | 38 | 0.140 |
Why?
|
| Length of Stay | 1 | 2020 | 736 | 0.140 |
Why?
|
| Maternal Age | 1 | 2016 | 45 | 0.140 |
Why?
|
| Pregnancy in Diabetics | 1 | 2016 | 38 | 0.140 |
Why?
|
| Comorbidity | 1 | 2020 | 949 | 0.140 |
Why?
|
| Syria | 1 | 2016 | 2 | 0.130 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1072 | 0.130 |
Why?
|
| Male | 5 | 2024 | 42411 | 0.130 |
Why?
|
| Arabs | 1 | 2016 | 17 | 0.130 |
Why?
|
| Unemployment | 1 | 2016 | 10 | 0.130 |
Why?
|
| Morals | 1 | 2017 | 94 | 0.130 |
Why?
|
| Terminology as Topic | 1 | 2017 | 221 | 0.130 |
Why?
|
| Insurance, Health | 1 | 2016 | 162 | 0.130 |
Why?
|
| Health Status Disparities | 1 | 2017 | 188 | 0.120 |
Why?
|
| Odds Ratio | 1 | 2016 | 683 | 0.120 |
Why?
|
| Child, Preschool | 1 | 2021 | 3731 | 0.120 |
Why?
|
| Treatment Refusal | 2 | 2024 | 62 | 0.110 |
Why?
|
| Ethics, Medical | 1 | 2016 | 307 | 0.110 |
Why?
|
| Delivery of Health Care | 3 | 2022 | 435 | 0.110 |
Why?
|
| Risk Assessment | 1 | 2020 | 2303 | 0.100 |
Why?
|
| Smoking | 1 | 2016 | 621 | 0.100 |
Why?
|
| Sex Distribution | 1 | 2012 | 171 | 0.100 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 428 | 0.100 |
Why?
|
| Surgical Wound Infection | 2 | 2024 | 201 | 0.090 |
Why?
|
| Anticoagulants | 2 | 2024 | 427 | 0.090 |
Why?
|
| Models, Theoretical | 1 | 2012 | 491 | 0.090 |
Why?
|
| Middle Aged | 3 | 2024 | 25974 | 0.080 |
Why?
|
| Uterine Hemorrhage | 1 | 2024 | 21 | 0.060 |
Why?
|
| Organ Size | 1 | 2024 | 371 | 0.060 |
Why?
|
| Uterus | 1 | 2024 | 222 | 0.050 |
Why?
|
| Refusal to Treat | 1 | 2022 | 27 | 0.050 |
Why?
|
| Health Facilities | 1 | 2022 | 36 | 0.050 |
Why?
|
| Focus Groups | 1 | 2022 | 172 | 0.050 |
Why?
|
| Women's Health | 1 | 2022 | 102 | 0.050 |
Why?
|
| Heart Rate, Fetal | 1 | 2021 | 17 | 0.050 |
Why?
|
| Uterine Contraction | 1 | 2021 | 9 | 0.050 |
Why?
|
| Needs Assessment | 1 | 2022 | 157 | 0.050 |
Why?
|
| Obesity, Morbid | 1 | 2024 | 233 | 0.050 |
Why?
|
| Vital Signs | 1 | 2021 | 38 | 0.050 |
Why?
|
| Gender Identity | 1 | 2021 | 53 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2024 | 856 | 0.050 |
Why?
|
| Health Resources | 1 | 2021 | 81 | 0.050 |
Why?
|
| Placenta | 1 | 2022 | 179 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2024 | 451 | 0.040 |
Why?
|
| Czechoslovakia | 1 | 2019 | 2 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2022 | 385 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 1714 | 0.040 |
Why?
|
| Health Personnel | 1 | 2019 | 215 | 0.030 |
Why?
|
| Obesity | 1 | 2022 | 971 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2018 | 8241 | 0.020 |
Why?
|